Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data.
It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.
The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has commenced trading.
Stocks highlighted in yellow have made market-moving announcements (click headings to sort).
| Code | Company | Price | % | Volume |
| AEE | Aura Energy | 0.3 | 592 | 7158696 |
| WOO | Wooboard Tech Ltd | 0.002 | 100 | 330000 |
| KCN | Kingsgate Consolid. | 1.14 | 39 | 1063980 |
| ADD | Adavale Resource Ltd | 0.087 | 32 | 19942469 |
| OZM | Ozaurum Resources | 0.19 | 27 | 1513652 |
| BAS | Bass Oil Ltd | 0.0025 | 25 | 427563 |
| CCE | Carnegie Cln Energy | 0.0025 | 25 | 715535 |
| VIA | Viagold Rare Earth | 0.255 | 21 | 40 |
| TSC | Twenty Seven Co. Ltd | 0.006 | 20 | 5602060 |
| MTC | Metalstech Ltd | 0.495 | 18 | 1012472 |
After a 16 month suspension Aura Energy (ASX:AEE) was reinstated to trading and despite raising capital at 2.6 cents a share it rose to over 30 cents which is almost 600% higher than what it last traded at.
Adavale Resources (ASX:ADD), another uranium play, rocketed after telling shareholders it was commencing exploration at its South Australian assets.
Thailand focused gold explorer Kingsgate Consolidated (ASX:KCN) rose after an update to shareholders on its efforts to get permission to restart operations.
| Code | Company | Price | % | Volume |
| ANL | Amani Gold Ltd | 0.0015 | -25 | 79497462 |
| EVE | EVE Investments Ltd | 0.003 | -25 | 574610 |
| GMD | Genesis Minerals | 0.15 | -17 | 24062088 |
| TLX | Telix Pharmaceutical | 5.89 | -13 | 310830 |
| EME | Energy Metals Ltd | 0.37 | -12 | 16562 |
| SKS | SKS Tech Group Ltd | 0.18 | -10 | 158792 |
| MTB | Mount Burgess Mining | 0.055 | -8 | 80000 |
| AFW | Applyflow Limited | 0.065 | -7 | 7729730 |
| GTI | Gratifii | 0.027 | -7 | 3060 |
| 1ST | 1St Group Ltd | 0.015 | -6 | 6594 |
Telix Pharmaceuticals (ASX:TLX) dropped after the FDA extended the review period for its prostate cancer drug Illuccix by three months.